Hydroxychloroquine, lopinavir, favipiravir, remdesivir have not proved effectiveness in COVID-19 treatment - pharmacologist

Kyrgyzstan|health|July 16, 2020 / 05:15 PM

AKIPRESS.COM - The fact that antiviral drugs were not included into COVID-19 treatment protocols in Kyrgyzstan is widely criticized, Kyrgyz Health Ministry's senior pharmacologist Aida Zurdinova told a press briefing today...

To Read the Full Story

Republication of any material is prohibited without a written agreement with AKIpress News Agency.

Any citation must be accompanied by a hyperlink to akipress.com.

Our address:

299/5 Chingiz Aitmatov Prosp., Bishkek, the Kyrgyz Republic

e-mail: english@akipress.org, akipressenglish@gmail.com;

Log in

Forgot your password? - recover

Not registered yet? - sign-up

Sign-up

I have an account - log in

Password recovery

I have an account - log in